Secondary Logo

Journal Logo

Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity

Goulding, Krista A. MD, MPH1,a; Schwartz, Adam MD2,b; Hattrup, Steven J. MD2; Randall, Lor R. MD3; Lee, Donald MD4; Rispoli, Damian M. MD5; Lerman, Daniel M. MD6; Beauchamp, Christopher MD2

Clinical Orthopaedics and Related Research®: June 2017 - Volume 475 - Issue 6 - p 1752–1752
doi: 10.1007/s11999-017-5299-4
Erratum
Free

1McGill University Health Centre, 1650 Avenue Cedar, H3G 1A4, Montreal, QC, Canada

2The Mayo Clinic, Mayo Clinic Hospital, Phoenix, AZ, USA

3Huntsman Cancer Institute, Salt Lake City, UT, USA

4Vanderbilt Orthopaedic Institute Medical Center East, Nashville, TN, USA

5Holy Spirit Hospital, A Gesinger Affiliate Associate, Danville, PA, USA

6University of Maryland Greenebaum Cancer Center, Baltimore, MD, USA

ae-mail; krista.goulding@mcgill.ca

be-mail; schwartz.adam@mayo.edu

The online version of the original article can be found under doi:10.1007/s11999-017-5258-0.

Back to Top | Article Outline

Erratum to: Clin Orthop Relat Res DOI: 10.1007/s11999-017-5258-0

A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.”

The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.”

We apologize for the error.

© 2017 Lippincott Williams & Wilkins LWW